2-Methoxy-5-(trifluoromethyl)benzonitrile | CAS:34636-92-5

We serve 2-Methoxy-5-(trifluoromethyl)benzonitrile CAS:34636-92-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Methoxy-5-(trifluoromethyl)benzonitrile

Chemical Name:2-Methoxy-5-(trifluoromethyl)benzonitrile
CAS.NO:34636-92-5
Synonyms:2-Methoxy-5-(trifluoromethyl)benzonitrile
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 256.8±40.0 °C at 760 mmHg
Melting Point 30-34℃
Molecular Formula C9H6F3NO
Molecular Weight 201.145
Flash Point 109.1±27.3 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.464
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 2-Methoxy-5-(trifluoromethyl)benzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methoxy-5-(trifluoromethyl)benzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methoxy-5-(trifluoromethyl)benzonitrile Use and application,2-Methoxy-5-(trifluoromethyl)benzonitrile technical grade,usp/ep/jp grade.


Related News: Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.Raspberry ketone glucoside manufacturer Pharmaceutical intermediates and APIs belong to the fine chemical industry.3-Methyl-3-Pyrazolin-5-One supplier The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.4-Fluoro-3-nitrotoluene vendor The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.The US National Institutes of Health is working on a preventative vaccine, but it will likely take a few months until the first phase of clinical trials get underway, and more than a year until a vaccine might be available, according to experts.